Will our current success in treating rheumatoid arthritis hinder new drug development? That is the question!!
Weinblatt
M E
ME
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004341:Drug Evaluation; D006801:Humans; D018579:Patient Selection; D012107:Research Design; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha